MYSTERIOUS: 3 - What They Never Told You

Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2022

Upgrades

Benzinga · Jul 20, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2022

Upgrades

Benzinga · Jul 14, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022

Upgrades

Benzinga · Jul 13, 2022

Take Advantage of These 5 'Strong Buy' Stocks Down More Than 10% YTD

Amid deepening supply disruptions and record-high inflation, expected aggressive federal interest rate increases, and the resurgence of COVID-19 cases have been driving market volatility. However, we think quality stocks Agilent (A), Olympus (OCPNY), F5 (FFIV), Jones Lang LaSalle (JLL), and United Therapeutics (UTHR), which are down more than 10% in…

StockNews.com · Mar 28, 2022

A Bearish Sign Appears On F5's Chart

If history is any guide, there may be trouble ahead for shares of F5 (NASDAQ:FFIV). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga · Mar 18, 2022

Analysts Cut F5 Price Target Following Lack-Lustre Outlook

Analysts 

Benzinga · Jan 26, 2022

Expert Ratings For F5

Over the past 3 months, 8 analysts have published their opinion on F5 (NASDAQ:FFIV) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga · Jan 26, 2022

Benzinga Pro's Top 5 Stocks To Watch For Wednesday, Jan. 26, 2022: HES, FFIV, TXN, LVS, AAPL

Today's 5 Stock Ideas: Hess (HES) - Shares up premarket. The company reported better-than-expected Q4 EPS results. F5 (FFIV) - Shares down premarket. The company issued Q2 sales guidance below

Benzinga · Jan 26, 2022

Recap: F5 Q1 Earnings

F5 (NASDAQ:FFIV) reported its Q1 earnings results on Tuesday, January 25, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Benzinga · Jan 25, 2022